These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64. Optical chemosensors and reagents to detect explosives. Salinas Y; Martínez-Máñez R; Marcos MD; Sancenón F; Costero AM; Parra M; Gil S Chem Soc Rev; 2012 Feb; 41(3):1261-96. PubMed ID: 21947358 [TBL] [Abstract][Full Text] [Related]
65. [High performance liquid chromatographic method for determination of procainamide and its active metabolites, N-acetylprocainamide in serum]. Zhang SQ; Olugo-Edege GC; Zhu YP; Mao FF; An DK Yao Xue Xue Bao; 1988 Jun; 23(6):430-4. PubMed ID: 2463733 [No Abstract] [Full Text] [Related]
66. Relationship between plasma levels of procainamide, suppression of premature ventricular complexes and prevention of recurrent ventricular tachycardia. Myerburg RJ; Kessler KM; Kiem I; Pefkaros KC; Conde CA; Cooper D; Castellanos A Circulation; 1981 Aug; 64(2):280-90. PubMed ID: 7249296 [TBL] [Abstract][Full Text] [Related]
67. The pharmacokinetics of procainamide in normal subjects using a specific gas chromatographic assay. Simons KJ; Levy RH; Cutler RE; Christopher GT; Lindner A Res Commun Chem Pathol Pharmacol; 1975 Jun; 11(2):173-85. PubMed ID: 1153866 [TBL] [Abstract][Full Text] [Related]
68. Increased procainamide plasma concentrations caused by quinidine: a new drug interaction. Hughes B; Dyer JE; Schwartz AB Am Heart J; 1987 Oct; 114(4 Pt 1):908-9. PubMed ID: 3661379 [No Abstract] [Full Text] [Related]
69. Determination of the steady-state volume of distribution using arterial and venous plasma data from constant infusion studies with procainamide. Lam G; Chiou WL J Pharm Pharmacol; 1982 Feb; 34(2):132-4. PubMed ID: 6121879 [No Abstract] [Full Text] [Related]
70. Improved semi-automated analysis of procainamide and N-acetyl procainamide utilizing a totally volatile mobile phase. Quattrone AJ; Putnam RS J Anal Toxicol; 1981; 5(2):101-4. PubMed ID: 6165861 [TBL] [Abstract][Full Text] [Related]
72. Pharmacokinetics of drugs in blood III: Metabolism of procainamide and storage effect of blood samples. Chen ML; Lee MG; Chiou WL J Pharm Sci; 1983 May; 72(5):572-4. PubMed ID: 6191022 [No Abstract] [Full Text] [Related]
73. Plasma concentration of procainamide and prevalence of exertional arrhythmias. Gey GO; Levy RH; Fisher L; Pettet G; Bruce RA Ann Intern Med; 1974 Jun; 80(6):718-22. PubMed ID: 4832159 [No Abstract] [Full Text] [Related]
74. Serum procainamide analysis based on acetonitrile stacking by capillary electrophoresis. Shihabi ZK Electrophoresis; 1998 Nov; 19(16-17):3008-11. PubMed ID: 9870404 [TBL] [Abstract][Full Text] [Related]
75. Cumulation of N-acetylprocainamide, an active metabolite of procainamide, in patients with impaired renal function. Drayer DE; Lowenthal DT; Woosley RL; Nies AS; Schwartz A; Reidenberg MM Clin Pharmacol Ther; 1977 Jul; 22(1):63-9. PubMed ID: 872496 [TBL] [Abstract][Full Text] [Related]
76. [Simultaneous determination of free cholesterol and total cholesteron on an AA I Technicon autoanalyzer (authors transl)]. Heuck CC; Wirth A J Clin Chem Clin Biochem; 1977 Apr; 15(4):213-6. PubMed ID: 864382 [TBL] [Abstract][Full Text] [Related]